| # | Title | Journal | Year | Citations |
|---|
| 1 | Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial | Lancet, The | 2015 | 1,042 |
| 2 | A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal | Modern Pathology | 2018 | 739 |
| 3 | ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease | Annals of Oncology | 2019 | 665 |
| 4 | Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis | Pathology | 2011 | 401 |
| 5 | The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer | International Journal of Gynecological Cancer | 2018 | 336 |
| 6 | ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease | International Journal of Gynecological Cancer | 2019 | 167 |
| 7 | Data set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR) | Modern Pathology | 2015 | 164 |
| 8 | Mesonephric Adenocarcinomas of the Uterine Cervix and Corpus | American Journal of Surgical Pathology | 2012 | 146 |
| 9 | Lifestyle Risk Factors for Serrated Colorectal Polyps: A Systematic Review and Meta-analysis | Gastroenterology | 2017 | 135 |
| 10 | An Immunohistochemical Study of Cervical Neuroendocrine Carcinomas: Neoplasms That are Commonly TTF1 Positive and Which May Express CK20 and P63 | American Journal of Surgical Pathology | 2010 | 127 |
| 11 | The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients with Cervical Cancer | Virchows Archiv Fur Pathologische Anatomie Und Physiologie Und Fur Klinische Medizin | 2018 | 127 |
| 12 | Hormone receptor‐negative, thyroid transcription factor 1‐positive uterine and ovarian adenocarcinomas: report of a series of mesonephric‐like adenocarcinomas | Histopathology | 2016 | 125 |
| 13 | GATA3 Is a Sensitive and Specific Marker of Benign and Malignant Mesonephric Lesions in the Lower Female Genital Tract | American Journal of Surgical Pathology | 2015 | 124 |
| 14 | Human papillomavirus prevalence and type‐distribution in cervical glandular neoplasias: Results from a European multinational epidemiological study | International Journal of Cancer | 2015 | 122 |
| 15 | BCOR Internal Tandem Duplication in High-grade Uterine Sarcomas | American Journal of Surgical Pathology | 2018 | 118 |
| 16 | Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract | Modern Pathology | 2015 | 111 |
| 17 | Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract | American Journal of Surgical Pathology | 2018 | 110 |
| 18 | Incidental Nonuterine High-grade Serous Carcinomas Arise in the Fallopian Tube in Most Cases | American Journal of Surgical Pathology | 2015 | 104 |
| 19 | Uterine Inflammatory Myofibroblastic Tumors Frequently Harbor ALK Fusions With IGFBP5 and THBS1 | American Journal of Surgical Pathology | 2017 | 103 |
| 20 | Pathology of Neuroendocrine Tumours of the Female Genital Tract | Current Oncology Reports | 2017 | 91 |
| 21 | Uterine and vaginal sarcomas resembling fibrosarcoma: a clinicopathological and molecular analysis of 13 cases showing common NTRK-rearrangements and the description of a COL1A1-PDGFB fusion novel to uterine neoplasms | Modern Pathology | 2019 | 89 |
| 22 | New developments in endocervical glandular lesions | Histopathology | 2013 | 87 |
| 23 | The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type | Gynecologic Oncology | 2016 | 85 |
| 24 | Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology | Histopathology | 2017 | 84 |
| 25 | Small-Cell Carcinoma of the Ovary, Hypercalcemic Type–Genetics, New Treatment Targets, and Current Management Guidelines | Clinical Cancer Research | 2020 | 82 |
| 26 | Sentinel lymph node (SLN) concept in cervical cancer: Current limitations and unanswered questions | Gynecologic Oncology | 2019 | 81 |
| 27 | The developing spectrum of gastric-type cervical glandular lesions | Pathology | 2018 | 77 |
| 28 | Patterns of p53 immunoreactivity in endometrial carcinomas: ‘all or nothing’ staining is of importance | Histopathology | 2011 | 76 |
| 29 | Clinicopathologic Characteristics of Mesonephric Adenocarcinomas and Mesonephric-like Adenocarcinomas in the Gynecologic Tract | American Journal of Surgical Pathology | 2021 | 76 |
| 30 | Low-Grade Ovarian Serous Neoplasms (Low-Grade Serous Carcinoma and Serous Borderline Tumor) Associated With High-Grade Serous Carcinoma or Undifferentiated Carcinoma | American Journal of Surgical Pathology | 2012 | 75 |
| 31 | Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data | Gynecologic Oncology | 2019 | 74 |
| 32 | Concurrent and future risk of endometrial cancer in women with endometrial hyperplasia: A systematic review and meta-analysis | PLoS ONE | 2020 | 73 |
| 33 | Immunohistochemistry in the distinction between primary and metastatic ovarian mucinous neoplasms: Table 1 | Journal of Clinical Pathology | 2012 | 71 |
| 34 | High‐grade serous carcinoma of tubo‐ovarian origin: recent developments | Histopathology | 2017 | 71 |
| 35 | Molecular subgroup of high-grade serous ovarian cancer (HGSOC) as a predictor of outcome following bevacizumab. | Journal of Clinical Oncology | 2014 | 71 |
| 36 | Assignment of primary site in high‐grade serous tubal, ovarian and peritoneal carcinoma: a proposal | Histopathology | 2014 | 69 |
| 37 | Metastatic Carcinomas in the Cervix Mimicking Primary Cervical Adenocarcinoma and Adenocarcinoma In Situ | American Journal of Surgical Pathology | 2010 | 68 |
| 38 | Yolk sac tumours of the female genital tract in older adults derive commonly from somatic epithelial neoplasms: somatically derived yolk sac tumours | Histopathology | 2016 | 66 |
| 39 | Ovarian Seromucinous Carcinoma | American Journal of Surgical Pathology | 2015 | 64 |
| 40 | Primary site assignment in tubo-ovarian high-grade serous carcinoma: Consensus statement on unifying practice worldwide | Gynecologic Oncology | 2016 | 60 |
| 41 | HMGA2 is a Sensitive But Not Specific Immunohistochemical Marker of Vulvovaginal Aggressive Angiomyxoma | American Journal of Surgical Pathology | 2010 | 59 |
| 42 | Recent Developments in Non–HPV-related Adenocarcinomas of the Lower Female Genital Tract and Their Precursors | Advances in Anatomic Pathology | 2016 | 58 |
| 43 | A practical approach to the diagnosis of mixed epithelial and mesenchymal tumours of the uterus | Modern Pathology | 2016 | 57 |
| 44 | Chemotherapy or upfront surgery for newly diagnosed advanced ovarian cancer: Results from the MRC CHORUS trial. | Journal of Clinical Oncology | 2013 | 55 |
| 45 | Small-Cell Carcinoma of the Ovary of Hypercalcemic Type (Malignant Rhabdoid Tumor of the Ovary) | Surgical Pathology Clinics | 2016 | 53 |
| 46 | The pathology of and controversial aspects of ovarian borderline tumours | Current Opinion in Oncology | 2010 | 52 |
| 47 | Data Set for Reporting of Endometrial Carcinomas | International Journal of Gynecological Pathology | 2013 | 52 |
| 48 | Loss of SMARCA4 (BRG1) protein expression as determined by immunohistochemistry in small‐cell carcinoma of the ovary, hypercalcaemic type distinguishes these tumours from their mimics | Histopathology | 2016 | 52 |
| 49 | Uterine tumour resembling ovarian sex cord tumour: first report of a large series with follow‐up | Histopathology | 2017 | 52 |
| 50 | Misplaced Skeneʼs Glands | International Journal of Gynecological Pathology | 2011 | 51 |
